Ashwath Jayagopal, Chief Scientific & Development Ofc at Ocuphire Pharma, Inc. (OCUP), bought 3,500 shares at $1.77 ($6K) on 2024-05-22, disclosed to the SEC on 2024-05-24.
Open-market purchase of $6k OCUP by Chief Scientific & Development Ofc. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |